IRIS
DE ANGELIS, BIAGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.038
AS - Asia 911
EU - Europa 730
SA - Sud America 121
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 985
SG - Singapore 418
RU - Federazione Russa 348
VN - Vietnam 163
CN - Cina 142
IT - Italia 111
BR - Brasile 104
HK - Hong Kong 80
DE - Germania 60
FR - Francia 45
FI - Finlandia 41
CA - Canada 32
IE - Irlanda 26
BD - Bangladesh 25
GB - Regno Unito 25
NL - Olanda 25
JP - Giappone 23
IN - India 16
MX - Messico 11
PL - Polonia 11
UA - Ucraina 9
SE - Svezia 7
ZA - Sudafrica 7
AR - Argentina 6
LT - Lituania 5
PH - Filippine 5
CI - Costa d'Avorio 4
ES - Italia 4
ID - Indonesia 4
IQ - Iraq 4
PK - Pakistan 4
TH - Thailandia 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 3
BW - Botswana 3
JM - Giamaica 3
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
KR - Corea 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.828
Salva come PNG Salva come JPEG
Città #
Singapore 179
San Jose 154
Ashburn 94
Chandler 93
Hong Kong 74
Moscow 63
Beijing 49
Ho Chi Minh City 41
Munich 37
Hanoi 36
Santa Clara 31
Millbury 28
The Dalles 25
Council Bluffs 23
Frisco 23
Buffalo 21
Los Angeles 21
Turku 21
Dong Ket 20
Lauterbourg 20
Amsterdam 18
Rome 18
Tokyo 17
New York 16
São Paulo 15
Des Moines 14
Napoli 14
Dallas 13
Lawrence 13
London 12
Naples 12
Dublin 9
Princeton 9
Toronto 9
Atlanta 8
Boston 8
Frankfurt am Main 8
Nanjing 8
Nuremberg 8
Redondo Beach 8
Warsaw 8
Wilmington 8
Chennai 7
Haiphong 7
Orem 7
Seattle 7
Da Nang 6
Helsinki 6
Ottawa 6
Poplar 6
Brooklyn 5
Lappeenranta 5
Milan 5
Montreal 5
Rio de Janeiro 5
Falkenstein 4
Johannesburg 4
Mexico City 4
Phoenix 4
Redwood City 4
Salvador 4
Stockholm 4
Tianjin 4
Brussels 3
Denver 3
Fairfield 3
Frosinone 3
Guangzhou 3
Hefei 3
Houston 3
Jiaxing 3
Miami 3
Nanchang 3
Praia Grande 3
San Francisco 3
Sant'agata De' Goti 3
Woodbridge 3
Ankara 2
Bari 2
Bastia 2
Brescia 2
Cabo Frio 2
Changsha 2
Chicago 2
Concord 2
Curitiba 2
Dakar 2
Dalian 2
Gaborone 2
Giugliano In Campania 2
Guarulhos 2
Guidonia 2
Juiz de Fora 2
Kingston 2
Kochi 2
Kyiv 2
Lahore 2
Manchester 2
Medellín 2
Mumbai 2
Totale 1.503
Salva come PNG Salva come JPEG
Nome #
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies 173
UNA BASSA ESPRESSIONE DELLA FOSFATASI SHP-1 CORRELA CON LA RESI-STENZA AL TRATTAMENTO CON INIBITORI DELLE TIROSIN KINASI IN PAZIENTIAFFETTI DA LEUCEMIA MIELOIDE CRONICA 162
MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS 154
Adoptive immunotherapy using prame-specific t cells in medulloblastoma 144
L'ATTIVITÀ DEGLI INIBITORI DI TIROSINA KINASI (TKI) SULLA PROLIFERAZIONE E L'ATTIVAZIONE DELLE CELLULE T 143
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene 142
FGFR1 is a potential therapeutic target in neuroblastoma 138
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells 137
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib. 135
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism 123
Molecular monitoring in chronic myeloid leukemia (CML) 116
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma 113
Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing 111
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. 110
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 109
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 109
Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells 103
Generation of Epstein Barr Virus Specific Cytotoxic T Lymphocytes (EBV-CTLs) Resistant to the Immunosuppressive Drug Tacrolimus (FK506) 98
Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies 92
Overcoming challenges in CAR T-cell product CGMP release 92
Generation of EBV specific cytotoxic T lymphocytes (EBV-CTLs) resistant to the immunosuppressive drug FK506 88
Stimuli-responsive nanoparticle-assisted immunotherapy: A new weapon against solid tumours 82
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring 81
A biodegradable hydrogel based on carboxymethyl cellulose/silver nanoparticles for wound closures 15
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? 7
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial 7
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape 6
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches 6
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model 6
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers 6
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling 6
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma 5
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 5
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 5
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 5
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy 5
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies 4
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 4
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 4
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles 4
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant 4
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases 4
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 4
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system 3
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We? 3
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia 3
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 3
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression 3
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas 2
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma 2
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models 2
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts 2
Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report 2
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma 2
Totale 2.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022161 9 0 0 1 0 2 0 6 27 6 57 53
2022/2023219 22 13 8 4 32 25 8 33 36 17 15 6
2023/2024113 6 22 12 9 5 11 2 11 2 3 20 10
2024/2025735 29 20 0 9 19 51 68 63 48 73 274 81
2025/20261.448 155 62 155 135 255 52 163 48 140 117 105 61
2026/202760 60 0 0 0 0 0 0 0 0 0 0 0
Totale 2.894